Search results

Date: 2024-04-09 Tridentify are delighted to announce that Intrance Medical Systems Inc. now have signed a LOI purchase commitment of $ 300 000. Our Tridentify safeguarding solution will be used for the “logistic journey” of the drug component for clinical trials in at least Europe and the US for patients with Parkinson diseases in advanced stage. The clinical development program for US registration has recently been initiated, with a larger more extensive study planned for late 2024. - Intrance Medical Systems is focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease. The product, Lecigon, is successfully marketed and available across Europe (by Britannia Pharmaceuticals). Intrance Medical plans to bring this innovative system to the US, Canada, Japan, Taiwan and LATAM. The US clinical development program includes key studies where accurate data to the FDA is paramount. Since Lecigon requires an unbroken cold supply chain and whose properties can change if improperly handled, we have found that Tridentify has a unique solution with monitoring and continuous calculation of remaining shelf life. We’re excited about our collaboration and anticipate extending our partnership in the future, says Patrick Shea, CEO at Intrance Medical Systems Inc. - Tridentify is excited about the next steps with Intrance Medical Inc. Together with Intrance we want to ensure high quality standards in their important development of a new Parkinson treatment. We are proud to be able to safeguard the shipments for the clinical trials in Europe and in the US, as well as to support the important safety for patients with severe diseases, says Ann-Christine Jungmar, CEO at Tridentify. About Tridentify AB Tridentify is a Swedish Software-as-a-Service MedTech company that helps customers control the entire supply chain and cold chain logistics for costly sensitive drugs, vaccines, blood, organs and other temperature-sensitive goods. The company has a unique and patented SaaS/IoMT system that monitors in real time the status of the product and continuously calculates its remaining shelf-life and that it safely fulfils its purpose. With the Safeguarding solution, you always have a close eye on how your temperature sensitive products are doing during the journey. Unlike other solutions, Tracer System® is programmed to understand and sense exactly how different types of medicines, vaccines, blood, plasma and organs are affected during a transport, throughout the life cycle of the products. With our medical technology - not just a logistics tool - sensitive goods can be put into use immediately after delivery without a formal QA. A revolution in industry to save time, money and most importantly - ensure security and functionality for the end user!  Our technology makes it safer and easier to comply with current and future legislation and medical requirements. In the end, this means safe products, safe patients and minimal wastage. Tridentify has a SaaS solution using a unique IoT Tracer that is a MDD MedTech Device Class IIa*. *MDD Certificate extended to end of 2028 due to Article 120 of MDR For more information, visit tridentify.com About Intrance Medical Systems Inc Intrance Medical Systems, Inc., is a private, U.S.-based biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S., Canada, South America, Japan and Taiwan. Intrance’s lead product, known as Lecigon® in the European market, is a fixed-dose combination treatment of levodopa, carbidopa and entacapone for enteral infusion in advanced Parkinson’s disease patients. The company has received FDA clearance for its IND application and is advancing its clinical development program for this targeted indication. For more information, visit intrancemedical.com For further information, kindly contact: Ann-Christine Jungmar, CEO Tridentify +46 708 71 46 76 ann-christine.jungmar@tridentify.com

Ser framemot att delta på QA Forum och ta del av nyheter inom GMP, GDP, best practices och andra kvalitetsförändringar. Flera intressanta föreläsningar och diskussioner kring erfarenheter, lärdomar, brist på läkemedel, kvalitetssäkring mm. Vår molnbaserade Medtech SaaS/IoMT lösning kan användas i kylkedjelogistiken av t ex kostsamma och känsliga läkemedel, vacciner mm. Vi beräknar kontinuerligt stabilitetsdata - säkra produkter, säkra patienter och minimerad kassation. Vill du veta mer? Hoppas vi ses där ! Ann-Christine Jungmar, CEO

Tridentify AB has signed a contract with Intrance Medical Systems regarding the purchase and delivery of the Tridentify Tracer Solution. The Seller (Tridentify AB) has developed an advanced SaaS and IoT system for the real-time monitoring and continuous stability control of pharmaceuticals in the cold chain. The Buyer (Intrance Medical Systems Inc) has developed a drug/device treatment system for patients suffering from Parkinson´s diseases in an advanced stage. The drug component is expected to be delivered internationally and need to be transported under refrigerated conditions. The intended transaction involves the Seller providing the monitoring system as a fee for service, covering safeguarding services of shipments of the pharmaceutical products used in the Buyer´s clinical development program including clinics in the EU and the US. -  Tridentify is delighted about the interest that Intrance Medical Systems has shown in our Tracer Solution. We are proud that Intrance is to become our first signed biomedical customer and that we will be able to support the development of a new Parkinson treatment in the US, says Johan Stormlund, CEO at Tridentify. About Tridentify AB Tridentify is a Swedish Software-as-a-Service MedTech company that helps customers control the entire supply chain and cold chain logistics for transfusion medicine blood, plasma and other temperature-sensitive goods. After further development work, we can now provide our unique system to the entire spectrum of sensitive and expensive biomedicine. Our safeguarding Tracer System accurately measures temperature and condition, throughout the life cycle of biological and pharma products. Unlike all other solutions, the Tracer System® is programmed to the exact specifications of the medicine. This gives it the ability to communicate the shelf life of the actual individual package it is attached to in real time. With Tridentify's SaaS/IoT system, the costs of delivery audits are reduced. There is significantly less wastage and less destroyed biopharma. Our technology makes it safer and easier to comply with current and future legislation and medical requirements. Finally, and most importantly, we increase the safety for the patient who can trust that the Biopharma fulfills its function. For more information, visit tridentify.com About Intrance Medical Systems Inc Intrance Medical Systems, Inc., a subsidiary of Sweden-based Intrance Holdings AB, is a private biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S., Canada, South America, Japan and Taiwan. For more information, visit intrancemedical.com

Tridentify's recent participation in the highly anticipated ISB 2023 in Gothenburg was an enormous success! As one of the event's proud sponsors, we had the opportunity to showcase our revolutionary temperature monitoring system and connect with industry professionals from around the world. Representatives from various countries and diverse backgrounds visited our booth, providing us with a global perspective and reinforcing the importance of our temperature monitoring solution on an international scale. We had the privilege of engaging in meaningful discussions, exchanging insights, and exploring potential collaborations with industry leaders, healthcare professionals, and decision-makers. For those who couldn't attend ISB 2023, don't worry! We are committed to keeping you updated on the latest advancements in our temperature monitoring system and its successful implementations. Stay tuned to our social media channels, and website, for informative content, product updates, and testimonials from satisfied customers.

Tridentify looks forward to sponsoring and attending the 33rd ISBT congress in Gothenborg, June 17-21st. Come visit us at our booth #2927, and learn more about how our customers are saving up to 90% of their waste by using our temperature monitoring system.

Tridentify, a leading provider of supply chain monitoring and management solutions, is excited to announce the launch of their latest product – a real-time monitoring system for temperature-sensitive shipments that include GPS geo-tracking and real-time calculation of remaining stability budget. This new monitoring system provides an all-in-one solution for tracking temperature-sensitive shipments, providing users with real-time data on the location and temperature of their products. With GPS geo-tracking, customers can follow their shipments from start to finish, ensuring that they are delivered to the right location at the right time. The real-time calculation of remaining stability budget provides an additional layer of protection, reducing waste and increasing patient safety by ensuring that the products are stored at the correct temperature throughout the entire supply chain. "We are thrilled to launch this new monitoring system, which provides our customers with the ability to track their temperature-sensitive shipments in real-time, including GPS geo-tracking and real-time calculation of remaining stability budget," said Johan Stormlund, CEO of Tridentify. "This is a game-changer for the industry, as it will help our customers to reduce waste, increase patient safety and ultimately save lives."

Come join our roundtable session at Logipharma 2023. The topic is: Taking QA decisions in realtime based on algorithms". Join us as we discuss real time decision-making with Mr Johan Stormlund (Thought leader), CEO, Tridentify, Mr Tomas Fant (Co-leader), Pfizer, Temperature Controlled Logistics Projects Lead and Mr Brett Marshall (Co-leader), Zuellig Pharma, Corporate Head, Quality.Tuesday 25th April, at 15:25, Track C – Mastering Temperature Controlled Operations.Welcome!

Tridentify is a proud sponsor of Logipharma 2023. The event will be held in Lyon, France 25-27th April. I´m looking forward to meeting you all there. And I can promise we will have some exciting news to share during the event.

EU is about to update and reinforce the rules within the handling of blood, tissues and cells. This is to ensure quality and patient safety. Read more here: https://ec.europa.eu/commission/presscorner/detail/en/QANDA_22_4404 Tridentify is the only Medical Device approved temperature monitoring system, that will support future requirements. We need to end the wasting of both blood and pharmaceuticals!Contact Tridentify to get more information on how we can support decreasing your waste.

Tridentify is sponsoring the Nordic QA forum that will take place on 24th November, 2022. The conference is held at Clarion Copenhagen Airport, Denmark. Come visit our booth.

Watch this video and view how Tridentify temperature monitoring solution can be used for full end2end visibility in your supply chain.

Come and visit our booth #7 at the TCL conference in Düsseldorf, 7-9th June, 2022.